Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guérin induction
{{output}}
Background: In an era of Bacillus Calmette-Guérin (BCG) shortage, intravesical Gemcitabine/Docetaxel (Gem/Doce) is gaining popularity as an alternative treatment for non-muscle-invasive bladder cancer (NMIBC). We compared the ou... ...
